Wound Care Biologics Market Size

Wound Care Biologics Market Size

Wound care biologics market size was valued over USD 1.4 billion in 2018 and is expected to witness 9.5% CAGR from 2019 to 2025.

Rising incidences of burn injuries specifically in developing and underdeveloped countries will positively impact the wound care biologics industry growth during the forecast period. Countries such as Africa and Brazil have high number of burn cases. For instance, according to WHO, around 180,000 deaths are caused due to burns in low- and middle-income countries annually. Burns not only have high economic impact but also has disastrous effects on the victim’s skin. Burns are classified depending upon the severity of injury, several treatment options are available. Wound care biologics is one of the widely preferred treatments in case of burns as it enables fast recovery with minimum or no complications. Therefore, availability of superior quality synthetic substitutes and it’s growing demand in treatment of burns has proven beneficial for the industry growth.
 

Innovations in the wound care biologics will foster the industry growth in upcoming years. Key industry players operational in the wound care biologics industry spends rigorously on R&D to develop quality wound care biologics products. For instance, xenografts offered by the companies can introduce collagen in the wounds that enables dermal regeneration. The exogenous collagen provides three-dimensional structure for the tissue growth and these xenografts are absorbed after the wound has completely healed. Also, skin substitutes recently developed are extensively utilized for treating post-surgical wounds. Therefore, availability of superior quality wound care biologics will boost the industry growth in foreseeable future. However, high cost of the wound care biologic products may restrain the industry growth to some extent.